CompletedPhase 3NCT03025750

Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Statens Serum Institut
Principal Investigator
Ingrid Kromann
Statens Serum Institut
Intervention
IPV-Al SSI(biological)
Enrollment
800 target
Eligibility
All sexes
Timeline
2017 – 2017

Study locations (1)

Collaborators

Bill and Melinda Gates Foundation · Larix A/S · Vaxtrials S.A. · AJ Vaccines A/S

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03025750 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials